BVMed demands urgent clarification of SUDs (single-use medical devices) rules
This article was originally published in Clinica
Executive Summary
Under Germany's medical products law amendment (MPG), hospitals must give guarantees that reconditioned single-use medical devices are of equally high quality and performance as newly manufactured devices. This is the tone of a letter from the German industry association (BVMed) to the health committee of the Lower House of parliament (Bundestag). According to BVMed director Joachim Schmitt, the draft of the second MPG amendment law of June 1 does not require either hospitals or firms which recondition devices to comply with the guidelines for manufacturers laid down in the original MPG. This means that they are not subject to controls by auditors or certifying bodies.
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.